Last reviewed · How we verify
premeal insulin lispro mixtures — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
premeal insulin lispro mixtures (premeal insulin lispro mixtures) — Eli Lilly and Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| premeal insulin lispro mixtures TARGET | premeal insulin lispro mixtures | Eli Lilly and Company | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- premeal insulin lispro mixtures CI watch — RSS
- premeal insulin lispro mixtures CI watch — Atom
- premeal insulin lispro mixtures CI watch — JSON
- premeal insulin lispro mixtures alone — RSS
Cite this brief
Drug Landscape (2026). premeal insulin lispro mixtures — Competitive Intelligence Brief. https://druglandscape.com/ci/premeal-insulin-lispro-mixtures. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab